Blue Ox Healthcare Partners

Epic Sciences is a diagnostics company focused on cancer management through blood-based tests that identify and characterize circulating tumor cells from a minimally invasive sample. Its platform profiles single-cell phenotype and genotype, including biomarker expression levels, subcellular localization, morphologic features, and genotypic metrics, and supports next-generation sequencing, FISH, and single-cell genomics to detect and characterize CTCs. The company develops tests such as the Oncotype DX AR-V7 Nucleus Detect for metastatic castration-resistant prostate cancer and offers biopharma solutions. It collaborates with biotechnology and pharmaceutical companies and cancer centers worldwide to provide real-time biopsy material and data to guide personalized medicine. By enabling analysis of rare cells before and after treatment, Epic Sciences aims to improve cancer management. The company was founded in 2008 and is headquartered in San Diego, California.

Gemelli Biotech is a biotechnology company based in North Carolina that focuses on the human microbiome and diagnostics for irritable bowel syndrome (IBS). Founded in 2018, the company aims to enhance health outcomes by unlocking the potential of the microbiome through innovative diagnostics and therapeutics. Gemelli Biotech develops medical devices that utilize blood tests to assess elevated levels of specific antibodies associated with post-infectious irritable bowel syndrome. Additionally, it offers a breath test system designed to identify small intestinal bacterial overgrowth, thereby providing physicians with optimized diagnostic protocols for various IBS types. The company is committed to bringing its biotechnology innovations to market in a socially responsible and fiscally prudent manner.

Epic Sciences is a diagnostics company focused on cancer management through blood-based tests that identify and characterize circulating tumor cells from a minimally invasive sample. Its platform profiles single-cell phenotype and genotype, including biomarker expression levels, subcellular localization, morphologic features, and genotypic metrics, and supports next-generation sequencing, FISH, and single-cell genomics to detect and characterize CTCs. The company develops tests such as the Oncotype DX AR-V7 Nucleus Detect for metastatic castration-resistant prostate cancer and offers biopharma solutions. It collaborates with biotechnology and pharmaceutical companies and cancer centers worldwide to provide real-time biopsy material and data to guide personalized medicine. By enabling analysis of rare cells before and after treatment, Epic Sciences aims to improve cancer management. The company was founded in 2008 and is headquartered in San Diego, California.

Sera Prognostics, Inc. is a biotechnology company that develops diagnostic tests to predict a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other pregnancy complications. Using proteomics and bioinformatics, it discovers and commercializes blood-based biomarker tests and predictive analytics to guide early, personalized interventions and reduce healthcare costs associated with pregnancy complications. Founded in 2008 and based in Salt Lake City, Utah, Sera aims to improve maternal and neonatal outcomes by providing physicians with actionable risk information during pregnancy.

Sera Prognostics, Inc. is a biotechnology company that develops diagnostic tests to predict a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other pregnancy complications. Using proteomics and bioinformatics, it discovers and commercializes blood-based biomarker tests and predictive analytics to guide early, personalized interventions and reduce healthcare costs associated with pregnancy complications. Founded in 2008 and based in Salt Lake City, Utah, Sera aims to improve maternal and neonatal outcomes by providing physicians with actionable risk information during pregnancy.

Epic Sciences is a diagnostics company focused on cancer management through blood-based tests that identify and characterize circulating tumor cells from a minimally invasive sample. Its platform profiles single-cell phenotype and genotype, including biomarker expression levels, subcellular localization, morphologic features, and genotypic metrics, and supports next-generation sequencing, FISH, and single-cell genomics to detect and characterize CTCs. The company develops tests such as the Oncotype DX AR-V7 Nucleus Detect for metastatic castration-resistant prostate cancer and offers biopharma solutions. It collaborates with biotechnology and pharmaceutical companies and cancer centers worldwide to provide real-time biopsy material and data to guide personalized medicine. By enabling analysis of rare cells before and after treatment, Epic Sciences aims to improve cancer management. The company was founded in 2008 and is headquartered in San Diego, California.

RX Solutions LLC, based in Boynton Beach, Florida, specializes in medical prescription assistance services. The company helps lower-income individuals access fixed or reduced-cost prescription drugs through its medication assistance programs, which cover a range of medications including Trulicity, Victoza, and ProAir. RX Solutions identifies suitable Prescription Assistance Programs (PAPs) for consumers based on their specific medication needs and guides them through the process to secure subsidies and obtain their medications.

Infinity Behavioral Health Services, LLC is a Fort Lauderdale, Florida-based company that specializes in providing comprehensive billing and consulting services for behavioral health facilities engaged in substance abuse and mental health treatment. Established in 2011, the company offers a range of solutions, including electronic claim submissions, claim scrubbing software, and detailed billing with appropriate coding. It also manages follow-up on unpaid claims, negotiates single-case agreements and in-network contracts, and provides customized reporting services. Additionally, Infinity delivers consulting on various operational aspects, such as admissions processes, documentation templates, and care guidelines. The company's expertise extends to assisting clients with clinical documentation, program scheduling, and eligibility verification, ensuring that behavioral health providers can focus on patient care while maximizing their insurance revenue.

PatientMatters is a provider of comprehensive patient receivables solutions designed to enhance financial outcomes for hospitals while improving patient experiences. The company focuses on seven critical areas of cash leakage, including pre-registration, emergency room processes, point-of-service collections, patient advocacy, early-out programs, payment plans, and bad debt management. Through its innovative platform, PatientMatters integrates patient registration, bill estimation, and financial services with intelligent workflows, enabling hospitals to streamline operations and increase revenue realization. By leveraging unique data sets, the company facilitates educational and engagement initiatives that not only boost cash collections but also foster stronger relationships between patients and healthcare providers, aligning incentives for all parties involved.